IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Arch Venture Management, LLC

Q3 2023 Holdings

Filed 2023-11-14 | 7 holdings | $154.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Eqrx, Inc.COM26886C107$80.7M36,335,37552.4%
Verve Therapeutics, Inc.COM92539P101$26.6M2,008,80917.3%
Erasca, Inc.(ERAS)COM29479A108$21.8M11,055,55414.1%
Denali Therapeutics, Inc.(DNLI)COM24823R105$14.3M693,7499.3%
Gossamer BIO, Inc.(GOSS)COM38341P102$6.7M8,055,9164.4%
Unity Biotechnology, Inc.(UNBX)COM91381U200$2.4M1,004,8171.6%
Singular Genomics Systems, Inc.COM82933R100$1.4M3,798,9260.9%